Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    IBS03 - Real World Discussion about Testing in Low Income Countries (Ticketed Session) (In-person Access Only)

    • 07:30 - 08:15
    • 8/07/2022
    • Location: Hall C7
    • IASLC CME Accredited
    • Type: Interactive Breakfast Session
    • Track: Global Health, Health Services Research, and Health Economics
    • +

      IBS03.02 - Real World Discussion about Testing in Low Income Countries

      07:45 - 08:00  |  Presenter: Thanyanan Baisamut

      • Abstract

      Loading...

  • +

    EP02.01 - Early Stage Non-small Cell Lung Cancer - Biomarkers

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Early Stage Non-small Cell Lung Cancer - Biomarkers
    • +

      EP02.01-016 - Molecular Alterations and Clinical Prognostic Factors in Resectable Non-Small Lung Cancer

      Presenter: Thanaporn Thamrongjirapat

      • Abstract

      Loading...

  • +

    EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      EP08.02-108 - Osimertinib Long-Term Tolerability in Patients with EGFRm NSCLC Enrolled in the AURA Program or FLAURA Study

      Presenter: Marina Chiara Garassino

      • Abstract

      Loading...

  • +

    ES24 - Palliative Care Integration and QOL in Advanced Lung Cancer

    • 14:45 - 15:45
    • 8/08/2022
    • Location: Strauss 1/2
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Palliative and Supportive Care
    • +

      ES24.04 - Treatment Decision-Making for Patients with Complicated Bone Metastases

      14:59 - 15:11  |  Presenter: Thanyanan Baisamut

      • Abstract

      Loading...